Professional Documents
Culture Documents
Valuation-Market Approach
Valuation-Market Approach
值)
Introduction to Valuation:
The Market Approach
林家振
台灣大學管理學院商學研究所
The Market Approach
In practice:
Estimate the value of the subject company by analyzing the prices paid for
similar companies relative to some benchmark (e.g. price relative to
earnings per share).
Be sure to understand whether you intend to value the assets or the equity!
Beware of mixing up levered and unlevered items in the numerator and
denominator (e.g. Price/EBIT may be misleading)!
Comparable
Subject
Company
Company
Multiple of EBIT:
MVIC of comparable company $90 mil.
divide by: EBIT of comparable $15 mil.
EBIT multiple 6x EBIT
Comparable Subject
Company Company
What does this indicate about the value of the subject company?
Multiple of EBIT:
MVIC of comparable $90
mil.
Less: excess Net Working Capital (15)
Adjusted MVIC of comparable $75
divide by: EBIT of comparable $15
EBIT multiple 5X
EBIT
12 months
June 30, 1995 Dec. 31, 1995 June 30, 1996 Dec. 31, 1996
6 months 6 months
June 30, 1995 Dec. 31, 1995 June 30, 1996 Dec. 31, 1996
LTM
Take the latest reported fiscal year (12 months) results, add the latest reported
year-to-date quarterly results and subtract the respective historical quarterly
results. Check for significant changes in accounting policies.
R&D $0 $0 $0 $0 $0 $0
% revenues 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Plus: De pr. & Amort. $0.2 $0.2 $0.3 $0.1 $0.2 $0.4
Non-Re curring Exp (Inc) $0.0 $0.0 $0.0 $0.0 $0.0 $0.0
Inte re st Exp (Inc) ($0.02) $0.06 $0.11 $0.08 ($0.01) $0.02
Othe r Exp (Inc) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Ratios:
Adj. Total Cap. / Revenues 0.21
Adj. Total Cap. / EBITDA 9.43
Adj. Total Cap. / EBIT 12.69
Price / Earnings Per Share 14.35
Price / Book Value Per Share 1.41
Gross Margin 85 71 97 97
% revenues 17.5% 14.1% 16.2% 16.2%
R&D $0 $0 $0 0
% revenues 0.0% 0.0% 0.0% 0.0%
EBIT 10 (10) 13 13
% revenues 2.2% -1.9% 2.2% 2.2%
EBITDA 15 (6) 17 17
% revenues 3.0% -1.1% 2.8% 2.8%
Total Debt 67
Preferred Stock 3
Ratios:
Adj. Total Cap. / Revenues 0.2
Adj. Total Cap. / EBITDA 8.9
Adj. Total Cap. / EBIT 11.1
Price / Earnings Per Share (3.6)
Price / Book Value Per Share 0.7
Ratios: A B C D E F G H T arg e t
Adj. Total Cap. / Revenues 0.2 0.2 0.5 0.9 0.4 0.4 0.7 0.2 NA
Adj. Total Cap. / EBITDA 9.4 8.9 12.4 21.5 10.7 33.1 12.3 8.5 NA
Adj. Total Cap. / EBIT 12.7 11.1 15.1 22.4 12.8 36.4 13.7 9.4 NA
Price / Earnings Per Share 14.4 (3.6) 28.6 40.0 (54.3) 38.8 21.8 12.9 NA
Price / Book Value Per Share 1.4 0.7 1.7 5.4 3.3 3.7 4.2 2.0 NA
FY 94-96 Revenue Growth 26.2% 10.9% 18.7% 38.1% 35.2% 20.0% 30.3% 25.7% 25.0%
LTM Gross Margin 11.3% 16.2% 30.6% 7.8% 14.5% 4.5% 15.4% 6.1% 6.0%
LTM EBITDA Margin 2.2% 2.8% 4.0% 4.4% 3.8% 1.2% 5.3% 2.5% 2.0%
LTM EBIT Margin 1.6% 2.2% 3.3% 4.2% 3.2% 1.1% 4.8% 2.2% 1.5%
LTM Pretax Margin 1.6% -3.3% 3.3% 3.4% -0.7% 0.7% 4.7% 2.0% 1.4%
LTM Net Margin 1.7% -4.3% 2.0% 2.2% -0.7% 1.0% 3.1% 1.2% 0.8%
25
20
15
10
0
Avon Helene Curtis Noxell Minnetonka Neutrogena
MULTIPLE
x INDICATOR (e.g. EBIT)
ENTERPRISE VALUE ON A MINORITY BASIS
LESS DEBT
PLUS CONTROL PREMIUM
Implied Multiples in DCF - you can use market multiples to check the
reasonableness of key elements in a DCF analysis.
– Total PV of DCF/EBIT
– Total PV of DCF/EBITDA
– Gross Terminal Value of DCF/Terminal year EBIT
– Gross Terminal Value of DCF/Terminal year EBITDA